Immusant, Inc.
Records under this name other than patents Immusant, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Immusant, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,835,603 | Agents for the Treatment of Celiac Disease Lapsed on the fee record Ended Sep 16, 2026 · High confidence | Lapsed on the fee record | Ended Sep 16, 2026 | High confidence |
| US 9,464,120 | Compositions for Treatment of Celiac Disease Lapsed on the fee record Ended Oct 11, 2024 · Medium confidence | Lapsed on the fee record | Ended Oct 11, 2024 | Medium confidence |
| US 10,473,647 | Peptides for use in treatment and diagnosis of type 1 diabetes Lapsed on the fee record Ended Nov 12, 2023 · From the USPTO record | Lapsed on the fee record | Ended Nov 12, 2023 | From the USPTO record |
| US 10,449,228 | Dosage of a gluten peptide composition Lapsed on the fee record Ended Oct 22, 2023 · From the USPTO record | Lapsed on the fee record | Ended Oct 22, 2023 | From the USPTO record |
| US 10,370,718 | Use of HLA genetic status to assess or select treatment of celiac disease Lapsed on the fee record Ended Aug 6, 2023 · From the USPTO record | Lapsed on the fee record | Ended Aug 6, 2023 | From the USPTO record |